Anterogen - Crunchbase Company Profile & Funding

Q: Where is Anterogen's headquarters?

Anterogen is located in Geumgok, Kyonggi-do, South Korea.

Q: Who invested in Anterogen?

Anterogen has 4 investors including Company K Partners And Dayli Partners.

Q: When was the last funding round for Anterogen?

Anterogen closed its last funding round on obfuscated from a Post-IPO Equity round.

Overview

Anterogen

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Anterogen

CB Rank

1744689

Anterogen is a bio-venture company specializing in research and development of cell therapy products.

Founded

obfuscation

Public

Post-IPO Equity

Geumgok, Kyonggi-do, South Korea

11-50

anterogen.com

Biotechnology

Pharmaceutical

Wholesale

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Key People

Seong-gu Lee: Co-Chief Executive Officer
Sung-Koo Lee: Co-Chief Executive Officer

Details

Legal Name

Anterogen Co. Ltd.

Also Known As

안트로젠

Operating Status

Active

Stock Symbol

KOSDAQ:065660

Company Type

For Profit

Founders

Ike Wan Lee

About the Company

Anterogen is a bio-venture company specializing in research and development of cell therapy products and orphan drugs using adult stem cells.

Phone Number

+82-2-2104-0391

Predictions & Insights

Products & Services

Autologous Stem Cell Therapy

A cell therapy using a patient's own stem cells for treatment, focusing on regenerative applications.

Allogenic Stem Cell Therapy

A cell therapy using donor stem cells to treat patients, often involving scaffold-based delivery.

Research & Development

Anterogen is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Anterogen	4	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Company K Partners	—	Post-IPO Equity - Anterogen	—
Company K Partners	—	Post-IPO Equity - Anterogen	—
Company K Partners	—	Post-IPO Equity - Anterogen	—
Company K Partners	—	Post-IPO Equity - Anterogen	—
Company K Partners	—	Post-IPO Equity - Anterogen	—